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The integrin avb6 is a ®bronectin receptor that is
undetectable on normal keratinocytes in situ, but is
increased signi®cantly in wound healing and in
culture-established keratinocytes, suggesting that it
may promote changes associated with cell motility.
Using normal human oral keratinocytes we have
shown that cultured cells express relatively high
levels of avb6 and this integrin has a functional role
in both cell adhesion and migration towards ®bro-
nectin. We provide experimental evidence that the
increased expression of avb6 by normal human oral
keratinocytes results in coordinate changes, which
promote a more migratory phenotype. Thus
increased expression of avb6 results in a ®bronectin-
dependent increase in pro-matrix metalloproteinase
9, matrix metalloproteinase 9 activity increases nor-
mal human oral keratinocyte migration, and this
may be further dependent on plasmin activation.
The results suggest a key role for avb6 in these pro-
cesses and indicate a coordinated link between avb6
expression and upregulation of matrix metalloprotei-
nase 9. It appears that avb6 may function in normal
human oral keratinocyte migration through matrix-
metalloproteinase-9-dependent and -independent
mechanisms. Key words: integrins/ keratinocytes/ metal-
loproteinases/ migration. J Invest Dermatol 116:898±904,
2001
M
igration of epithelial cells into the underlying
connective tissue is a fundamental feature of many
processes including development and wound
healing. During migration epithelial cells alter
their cell±cell and cell±extracellular matrix inter-
actions and gain the ability to degrade connective tissue, either by
secreting proteolytic enzymes themselves or by utilizing enzymes
produced by other cells. Matrix metalloproteinases (MMPs) are one
such group of proteolytic enzymes that are capable of degrading
different substrates within the extracellular matrix. In fact, secretion
of MMPs, accompanied by altered cell adhesion molecules, is
critical for epithelial migration.
Integrins are a family of heterodimeric, cation-dependent, cell
membrane receptors expressed by a variety of cells. Integrins
mediate cell±extracellular matrix and cell±cell interactions and
facilitate many cell processes including adhesion, proliferation,
migration, and differentiation (Hynes, 1992). These functions are
modulated substantially by signals from the extracellular matrix
(Damsky and Werb, 1992).
Successful epithelial wound healing is associated with a
speci®c sequence of changes in the process of cell±matrix
adhesion and extracellular matrix degradation. De novo expres-
sion of the avb6 integrin by keratinocytes in both cutaneous
and oral wounds has been demonstrated in several studies
(Breuss et al, 1993; Clark et al, 1996; Haapasalmi et al, 1996)
and there is some evidence to suggest that re-epithelialization of
epidermal wounds is associated with a switch from avb5
expression to avb6 in the keratinocyte population (Clark et al,
1996). Similarly, during wound healing the type IV collagenase
MMP-9 is upregulated by keratinocytes whereas MMP-2
remains localized to the stroma (Salo et al, 1994). Type IV
collagenases degrade basement membrane, a critical step in the
detachment and migration of keratinocytes. Intriguingly, many
of these changes are similar to those seen in squamous cell
carcinoma where, in addition to changes in proteolytic activity,
there is loss of avb5 and de novo expression of avb6 (Breuss et
al, 1994; Jones et al, 1997). Thus squamous cell carcinoma may
represent a process of uncontrolled tissue remodeling.
The upregulation of avb6 by wound keratinocytes suggests
that this integrin heterodimer could have an active role in cell
movement. Huang et al (1998) reported greatly reduced
migration on ®bronectin and vitronectin by keratinocytes from
b6 knockout mice. Restoration of avb5 to a malignant
keratinocyte cell line resulted in a reversal of the malignant
phenotype with suppression of anchorage-independent growth
and increased capacity for terminal differentiation (Jones et al,
1996) whereas retrovirally mediated transduction of b6 cDNA
into this cell line signi®cantly increased ®bronectin-dependent
migration and was associated with increased expression of
MMP-9 (Thomas et al, 2001). Activation of MMP-9 signi®-
cantly enhanced cell migration and invasion in this system
(Thomas et al, 2001).
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In this study we have examined the functional signi®cance of
avb6 expression by primary oral keratinocyes established in tissue
culture. Our results show that such cultured keratinocytes express
high levels of functional avb6 and that MMP-9 upregulation by
keratinocytes plated on ®bronectin is avb6 dependent. Increased
expression of avb6 resulted in a ®bronectin-dependent increase in
pro-MMP-9; this MMP-9 activity increased migration and migra-
tion was shown to be further dependent on plasmin activation. The
results suggest a key role for avb6 in these processes and indicate a
coordinated link between avb6 expression and upregulation of
MMP-9.
MATERIALS AND METHODS
Antibodies and reagents Eight monoclonal antibodies (all of murine
origin unless stated) were used in this study. L230 (antihuman av) was
prepared in our laboratory from hybridoma cells obtained from the
American Type Culture Collection (Rockville, MD) (Weinacker et al,
1994). The anti-avb6 (E7P6 and R6G9) (Weinacker et al, 1994), anti-
avb6 (10D5; Huang et al, 1998), anti-a5b1 (P1D6), and anti-b1
(P4C10) antibodies were purchased from Chemicon International
(Harrow, U.K.). Anti-avb5 (P1F6) was obtained from Life
Technologies, Paisley, U.K. Fluorescein isothiocyanate (FITC) and
horseradish peroxidase conjugated rabbit antimouse antibodies were
purchased from Dako (High Wycombe, U.K.). Plasma ®bronectin and
bovine serum albumin (BSA) were purchased from Sigma Chemical
(Poole, Dorset, U.K.). Anti-MMP-9 (66-b), rabbit anti-MMP-9, TIMP-
1, and MMP inhibitor 1 were obtained from Calbiochem (Nottingham,
U.K.).
Cell culture The cells used in this study were normal human oral
keratinocytes (NHK) prepared as outgrowths from normal oral mucosa
obtained with permission during minor oral surgery procedures. The
preparation of cells from explant cultures was modi®ed from the method
described by Freshney (1987). Brie¯y the tissue was ®nely chopped into
small pieces, placed in 25 cm2 ¯asks in keratinocyte growth medium
(KGM) as described. KGM comprised a-modi®ed Eagle's medium (a-
MEM) containing 10% fetal bovine serum (Globepharm, Surrey, U.K.)
supplemented with 100 IU per liter penicillin, 100 mg per liter
streptomycin, and 2.5 mg per liter amphotericin B (Gibco BRL),
1.8 3 10±4 M adenine, 5 mg per ml insulin, 1 3 10±10 M cholera toxin,
0.5 mg per ml hydrocortisone, and 10 ng per ml epidermal growth factor
(Sigma). After 1 wk, outgrowth of cells was observed and the medium
was changed at this time. Cultures were fed every 48 h and were ready
for passage at about day 18. NHK in this study were used up to passage
2.
Flow cytometry Subcon¯uent cells were washed with phosphate-
buffered saline (PBS) and harvested by trypsin/ethylenediamine
tetraacetic acid (0.25% wt/vol, 5 mM). Cells were incubated with
primary antibody for 40 min at 4°C and washed twice with PBS. FITC-
conjugated secondary antibody was applied to the cells for 30 min at
4°C. Brie¯y, cells were washed twice with PBS and resuspended in
0.5 ml PBS with 10% fetal bovine serum. Labelled cells were scanned on
a FACSCalibur cytometer (Becton Dickinson) and analyzed using
Cellquest software, acquiring 1 3 104 events.
Adhesion assays Ninety-six well plates (Falcon 3912; Becton
Dickinson) were coated with plasma ®bronectin (Sigma). A 50 ml
®bronectin solution at a concentration of 10 mg per ml was added to the
wells and incubated at 37°C for 1 h. After incubation wells were washed
with PBS and then blocked with 0.5% BSA at 37°C for 30 min. Control
wells were incubated with 0.5% BSA. Cells were chromium [51Cr]
labeled (Brunner et al, 1976), washed, and resuspended in a-MEM
(1.5 3 104 cells per well). For blocking experiments, cells were
incubated with speci®c antibodies (as described in Results in each well)
for 10 min on ice. Plates were incubated at 37°C for 1 h. Non-adherent
cells were removed by ¯ooding plates with PBS (supplemented with
1 mM CaCl2 and 0.5 mM MgCl2). After two washes, the plates were
cut into individual wells and the radioactivity associated with each well
was determined in a gamma counter (1261 Multigamma; LKB Wallac,
Bromma, Sweden). The percent adhesion was expressed as the adherent
cell radioactivity as a proportion of the total cell input. The nonspeci®c
adhesion (attachment to wells coated with BSA) was subtracted.
Experiments were repeated on three occasions, in quadruplicate, with
similar results.
Immunolocalization of MMP-9 and av Two 3 104 cells were
plated onto 13 mm glass coverslips coated with ®bronectin (10 mg per
ml) and blocked with 0.5% BSA in PBS. Coverslips were incubated for
24 h at 37°C in 5% CO2. For MMP-9 analysis cells were incubated for
24 h in serum-free medium containing 1 mM monensin (Sigma) to block
protein secretion. Cells were rinsed twice in PBS, ®xed for 15 min in
10% formalin, and permeabilized with 0.1% Triton X-100 for 10 min,
followed by incubation for 60 min in wash buffer. L230 (anti-av; 18 mg
per ml) or 66-b (anti-MMP-9; 1:100) diluted in wash buffer was added
for 60 min at 4°C. Bound antibody was detected with FITC-conjugated
rabbit antimouse secondary antibody (Dako; 1:40). Actin was visualized
with TRITC-conjugated phalloidin (Sigma: 5 ng per ml). Coverslips
were washed three times for 5 min in wash buffer, mounted with
MOWIOL 4-88 (Novabiochem, Nottingham, U.K.: 0.1 g per ml of
Citi¯uor mounting medium), and viewed with a confocal laser scanning
microscope (Zeiss LSM510; Welwyn Garden City).
Preparation of cell supernatants for MMP determination Twenty-
four well plates were coated with 200 ml of ®bronectin at 10 mg per ml.
After incubation wells were washed with PBS and blocked with 0.1%
BSA for 30 min. 105 cells were seeded in additive-free a-MEM into
uncoated and ®bronectin-coated wells. For blocking experiments, cells
were incubated with speci®c antibodies (as described in Results) for
30 min at 4°C and plated in medium containing an excess of antibody.
Supernatant was sampled after 24 h at which time a cell count was
carried out. Conditioned medium was cleared of cells and debris by
centrifugation at 4000 rpm for 10 min followed by protein estimation
using the BCA protein assay reagent (Pierce Warriner, Chester, U.K.).
Zymography MMP-9 and MMP-2 activity were analyzed using
sodium dodecyl sulfate (SDS) polyacrylamide substrate gels. Gelatin
(bloom 300, Sigma) was added to a 12% acrylamide separating gel at a
®nal concentration of 1 mg per ml. To each gel, samples containing
equal protein (as determined by BCA protein assay; Pierce Warriner)
were mixed with nonreducing sample buffer (62.5 mM Tris-HCl,
pH 6.8, 10% glycerol, 2% SDS, 0.1% bromophenol blue) and added to
the gel without boiling. Molecular weight markers and MMP standards
were run on each gel. Following electrophoresis, gels were washed twice
in 2.5% Triton X-100 for 30 min at 37°C to remove the SDS. Gels
were incubated at 37°C overnight in developing buffer containing
50 mM Tris-HCl, 0.2 M NaCl, 5 mM CaCl2, and 0.02% Triton X-100.
Gels were stained with 0.5% Coomassie blue G250 in 30% methanol,
10% glacial acetic acid for 30 min and destained in the same solution
without Coomassie blue. Gelatin-degrading enzymes were identi®ed as
Figure 1. Flow cytometric analysis of integrin expression by
NHK. The geometric mean ¯uorescence (arbitary units, log scale) as
measured by ¯ow cytometry of cells labeled with anti-integrin antibodies
is shown. Negative control had secondary antibody only and has been
subtracted from the results. The ®gure shows a representative experiment
(ND, not detected). Flow cytometry con®rmed relatively high avb6
expression by NHK and demonstrated that NHK also express the a5b1
®bronectin receptor and show high expression of a6, b4, a3, and b1
integrin subunits.
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clear bands against the blue background of the stained gel. Images of
stained gels were captured under illumination using the UVP Imagestore
5000 (Ultra-Violet Products, U.K.) and exported for use on a PC using
the Scion image program (Scion; based on the Macintosh NIH Image
program developed at the National Institutes of Health, MD). The
intensity of the bands was measured by densitometric analysis and
comparisons were made within each gel to determine relative changes in
MMP activity. Data for each zymogram were expressed as relative
changes in MMP activity and these relative changes were compared with
repeat experiments. Direct comparison between separate gels was not
made, as the intensity of background staining was variable. Experiments
were repeated a minimum of three times, each time in triplicate, and are
discussed only if consistent observations were made.
Enzyme-linked immunosorbent assay (ELISA) Commercial ELISA
kits for MMP-9 were purchased from Amersham Life Science,
Buckinghamshire, U.K. Cell supernatants were prepared as for
zymography. A hundred microliters of concentrated sample was added to
each well and MMP-9 was detected with peroxidase labeled F(ab)
fragment of anti-MMP-9 antibody. The reaction was stopped by
addition of 50 ml 1 M H2SO4 and the resultant color change was read at
450 nm on a spectrophotometer (SLT Labinstruments, Austria).
Concentration was determined by interpolation from a standard curve
using known concentrations of MMP standards as supplied.
Migration assays Haptotactic cell migration assays were performed
using matrix-coated polycarbonate ®lters (8 mm pore size, Transwellâ,
Becton Dickinson). The membrane undersurface was coated with
®bronectin (10 mg per ml) in PBS for 1 h at 37°C and blocked with
migration buffer (0.5% BSA in a-MEM) for 30 min at 37°C. To assess
integrin and MMP-9 speci®city of migration, blocking antibodies or
chemical inhibitors, together with plasminogen (to activate MMP-9) (as
described in Results), were added for 30 min at 4°C prior to plating. The
lower chamber was ®lled with 500 ml of migration buffer, following
which cells were plated in the upper chamber of triplicate wells, at a
density of 4 3 104 in 100 ml of migration buffer, and incubated at 37°C
for 20 h. After 20 h, the cells in the lower chamber (including those
attached to the undersurface of the membrane) were trypsinized and
counted on a Casy 1 counter (Sharfe System, Germany).
Statistical analysis Data are expressed as the mean 6 SD of a given
number of observations. Where appropriate, one-way analysis of variance
was used to compare multiple groups. Comparisons between groups
were by Fisher's PLSD (set at 5% signi®cance). A p-value of less
than 0.05 was considered to be signi®cant.
RESULTS
Cultured keratinocytes show relatively high avb6
expression Levels of surface expression of integrins were
determined by ¯ow cytometry. NHK express low levels of avb5
(mean ¯uorescence 12) but much greater levels of avb6 (mean
¯uorescence 50) (Fig 1). Flow cytometry demonstrated that NHK
also express the a5b1 ®bronectin receptor and show high
expression of a6, b4, a3, and b1 integrin subunits.
Adhesion of NHK to ®bronectin is mediated by avb6 and
a5b1 NHK were plated onto ®bronectin in the presence or
Figure 2 NHK adhere to ®bronectin using both avb6 and a5b1
integrins. Adhesion to ®bronectin of NHK in the presence of control
antibody was 24% of the plated cells. Background binding to BSA-
coated wells was 5% and has been subtracted from the results. Results are
expressed relative to control antibody (= 100%). Adhesion of NHK was
blocked by antibodies to both avb6 (60% inhibition) and a5b1 (57%
inhibition), as well as against the av and b1 subunits (51% and 55%
inhibition, respectively). Maximal inhibition of adhesion was obtained
using a combination of anti-avb6 and anti-a5b1 (72% inhibition). The
adhesion of cells (28%) in the presence of combined antibodies indicates
that other ®bronectin receptors may also be expressed by NHK. The
®gure shows a representative experiment performed in quadruplicate.
Error bars represent standard deviation.
Figure 3. Upregulation of MMP-9 by NHK on ®bronectin is
avb6 dependent. Cell supernatant samples were analyzed by
zymography and ELISA. (A) Zymogram showing the upregulation of
MMP-9 by NHK when plated on ®bronectin (10 mg per ml). Control is
recombinant MMP-9 (Amersham). Note that under serum-free
conditions both MMP-9 and MMP-2 are present in pro-enzyme form.
(B) Zymogram showing inhibition of MMP-9 expression on ®bronectin
by anti-avb6 antibody. Control is recombinant MMP-9 (Amersham).
(C) Densitometric analysis of zymograms from representative experiments
showing MMP-9 expression by NHK cells on ®bronectin and following
blockade with anti-integrin antibodies. Results are expressed relative to
MMP-9 expression by NHK cells on ®bronectin (= 100). Error bars
represent standard deviation. (D) ELISA showing upregulation of MMP-
9 by NHK on ®bronectin. Error bars represent standard deviation. (E)
ELISA showing inhibition of MMP-9 on ®bronectin by NHK by anti-
avb6 antibody. Error bars represent standard deviation.
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absence of blocking antibodies against the av subunit, avb6, a5b1,
b1, or an irrelevant antibody (W6/32) against class I major histo-
compatibility complex (Fig 2). Combinations of these antibodies
also were used. Antibodies directed against avb6 (60% inhibition)
and a5b1 (57% inhibition) signi®cantly inhibited adhesion of NHK
to ®bronectin (as did antibodies against the av and b1 subunits;
51% and 55%, respectively). Maximal inhibition of NHK adhesion
to ®bronectin, however, required a combination of antibodies
against avb6 and a5b1 (72% inhibition). This demonstrates a
functional role for avb6 in NHK adhesion to ®bronectin and that
NHK may adhere through both a5b1 and avb6. The adhesion of a
percentage of NHK in the presence of the combined antibodies
indicates that other ®bronectin receptors may also be involved.
NHK upregulate secretion of MMP-9 on ®bronectin in an
avb6-dependent manner Expression of MMP-9 and MMP-2
by NHK on uncoated and ®bronectin-coated tissue culture plastic
was examined by zymography and ELISA. Both approaches gave
qualitatively and quantitatively similar results. Zymography on
supernatant samples from cells grown in serum-free medium
showed that the cells produced MMP-9 and MMP-2, and that the
enzymes were present in proenzyme form. In agreement with
previous studies the level of MMP-9 expression increased and the
level of MMP-2 decreased with time in culture (Kobayashi et al,
1997, 1998). When plated on ®bronectin, the NHK showed
signi®cant upregulation of MMP-9 (p < 0.001) (Fig 3A).
To test the integrin dependence of the MMP-9 upregulation on
®bronectin NHK were incubated with speci®c integrin-blocking
antibodies against av, avb5, avb6, a5b1, or b1 prior to plating. A
signi®cant reduction in MMP-9 levels was observed when av or
avb6 was inhibited (p = 0.03, p < 0.001, respectively; Fig 3B). In
contrast, expression of MMP-9 was not affected by the other
integrin-blocking antibodies (avb5, a5b1, or b1; Fig 3C), con-
®rming the speci®city of avb6 in mediating these effects. These
data con®rm that increased synthesis of MMP-9 by NHK in
response to cell adhesion to ®bronectin is mediated by the avb6
integrin.
Expression of MMP-9 was also quantitated by ELISA (Fig 3D,
E). This con®rmed the avb6-dependent increase in expression of
MMP-9 and MMP-2 even though the ELISA assay was less
sensitive than zymography. This method also con®rmed that NHK
produced increased amounts of MMP-9 with time in culture
(Kobayashi et al, 1997, 1998).
Subcellular distribution of MMP-9 and av We examined the
subcellular distribution of MMP-9 in NHK. Indirect
immunochemistry on NHK revealed that MMP-9 located to the
terminal aspects of ®lopodia in monensin-treated cells (Fig 4A,
arrow) or in larger submembranous vesicles (data not shown)
suggesting that alteration in the cell morphology affects MMP-9
distribution. The av subunit was detected in focal adhesions
(Fig 4B, upper arrow) and, interestingly, was also expressed strongly
on ®lopodia (Fig 4B, lower arrow).
avb6 functions in NHK migration towards ®bronectin To
determine whether avb6 and MMP-9 are involved in
keratinocyte migration, haptotactic migration assays were
performed using ®bronectin-coated Transwell ®lters. In serum-
free conditions the MMP-9 produced by NHK is in proenzyme
form. As plasmin can activate pro-MMP-9 (Ramos-DeSimone
et al, 1999), we added the plasmin precursor, plasminogen, to
some migration assays. This substrate could be cleaved by the
urokinase-type plasminogen activator (uPA), which is present on
NHK cells (data not shown). Figure 5(A) shows activation of
MMP-9 on addition of plasminogen. Speci®c MMP-9 inhibitors
were also included. Migration towards ®bronectin was reduced
signi®cantly by anti-avb6 antibody (39% inhibition; p = 0.014)
(Fig 5B). Interestingly, inhibition of a5b1 increased migration
(30% increase; p = 0.003) (Fig 5B), suggesting that this integrin
may function in a purely adhesive capacity and may be
inhibitory to cell migration. Migration was also reduced by
anti-b1 antibodies (28% inhibition; p = 0.023) suggesting that
integrins of the b1 family may also be involved in keratinocyte
migration towards ®bronectin. This is further suggested by the
observation that the greatest degree of inhibition was produced
by a combination of anti-av and anti-b1 antibodies (71%
inhibition; p = 0.001). In plasminogen-free assays, neither
MMP-9 nor uPA inhibitors inhibited cell migration indicating
that the cell movement is MMP-9 and uPA independent
(Fig 5B).
Activation of MMP-9 increases NHK migration towards
®bronectin In the presence of plasminogen, a signi®cant increase
in migration towards ®bronectin was observed (158%) (Fig 5C).
Thus relative to the plasminogen-free migration of cells treated
with the control antibody W6/32, there was a 58% increase in
migration (p = 0.001) (Fig 5C). This increase in migration could
be abolished by an anti-MMP-9 speci®c antibody (61% inhibition;
p < 0.001) and a speci®c MMP-9 chemical inhibitor (Calbiochem;
called in-1 in Fig 5C; 70% inhibition; p < 0.001). This indicates
that the observed increase in migration due to addition of
plasminogen was MMP-9 dependent, and demonstrates a
functional role for MMP-9 in NHK migration. Addition of the
uPA inhibitor amiloride produced a similar level of inhibition (72%
inhibition; p < 0.001) suggesting that MMP-9 is activated through
uPA-dependent generation of plasmin. Integrin inhibition
produced a similar pattern of migration to that seen in assays
without plasminogen, although in general the level of inhibition
was greater. Thus anti-avb6 antibodies inhibited migration by
62%, whereas anti-a5b1 antibodies again produced an increase in
migration (Fig 5B). Interestingly, blocking b1 integrins produced
more effective inhibition of migration in the presence of activated
MMP-9, suggesting a more prominent role for b1 integrins in cell
migration towards ®bronectin under these conditions. Once again
Figure 4. MMP-9 localizes to the terminal
aspects of av-positive ®lopodia. Cells were
examined on a confocal microscope for MMP-9
and av expression. The ®gure shows combined
red (actin) and green (A, MMP-9; B, av) images.
Magni®cation bar: 10 mm. Image A shows
localization of MMP-9 to the terminal aspects of
®lopodia (A, arrows). The ®lopodia in NHK are
strongly av positive (B, lower arrow). av also
localizes to focal adhesions (B, upper arrow).
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the maximal inhibition was produced when a combination of anti-
av and anti-b1 antibodies was used (90% inhibition; p < 0.001).
DISCUSSION
During the process of cutaneous and oral wound repair,
keratinocytes migrate over a provisional matrix of ®brin,
®bronectin, vitronectin, and tenascin (Clark et al, 1982; Cavani et
al, 1993). Keratinocyte locomotion is an essential process during
early wound healing, and cellular division only occurs after a lag
phase (Clark, 1985). Migrating and proliferating keratinocytes
degrade and reduce their contact with the basement membrane
allowing exposure to components of the extracellular matrix and
blood clot (Clark, 1985). Accordingly, keratinocytes modify the
expression, cell-surface distribution, and cytoskeletal association of
integrin receptors (Haapasalmi et al, 1996) and also gain the ability
to degrade connective tissue (Ravanti and Kahari, 2000).
Dissolution of the basement membrane by keratinocytes is
thought to be the prerequisite for epithelial cell migration into the
wound area. Gelatinases, which degrade type IV collagen (the
major component of basement membrane) and which also have a
broad substrate speci®city, are believed to be important in the initial
degradation of basement membrane and in the pericellular lysis that
occurs in the wound bed (Salo et al, 1991). In situ hybridization
studies of MMP-2 or MMP-9 expression in skin and oral mucosal
wounds have localized MMP-9 mRNA expression to keratinocytes
and MMP-2 mRNA to ®broblasts in the wound bed (Oikarinen et
al, 1993; Salo et al, 1994).
Expression of the integrin avb6 appears to be restricted to a
subset of epithelial cells (Breuss et al, 1993, 1995) and in adult
tissues, with the exception of secretory phase endometrium, is
expressed at very low or undetectable levels (Breuss et al, 1995). In
contrast to this, avb6 expression is increased dramatically during
development, following injury or in¯ammation, and in a variety of
epithelial neoplasms (Breuss et al, 1995; Agrez et al, 1996; Jones et
al, 1997). Several studies have demonstrated the upregulation of
avb6 integrin by keratinocytes in both cutaneous and oral wounds
(Breuss et al, 1994; Clark et al, 1996; Haapasalmi et al, 1996)
although the exact function of this heterodimer remains unclear.
Whereas avb6 expression is not detectable on normal keratinocytes
in vivo, strong expression is found in cultured cells where conditions
may mimic a wound environment (Huang et al, 1998).
De novo expression of avb6 has been shown to modulate several
cellular processes in colon carcinoma cells including cell adhesion
and spreading on ®bronectin, proliferation within collagen gels, and
MMP-9 upregulation (Agrez et al, 1994; Weinacker et al, 1994;
Niu et al, 1998). Similarly, Thomas et al (2001) demonstrated
upregulation of MMP-9 in b6-transfected squamous carcinoma
cells. Huang et al (1998) found that avb6 has a critical role in
keratinocyte migration on ®bronectin (and vitronectin) and that
this effect is enhanced by protein kinase C activation. Apparently
somewhat paradoxically cutaneous wounds heal uneventfully in
b6±/±mice (Huang et al, 1996), though it might be that early
deletion of b6 leads to other integrin receptors ful®lling the role of
the avb6 heterodimer.
In this report we demonstrate avb6-dependent upregulation of
MMP-9 by NHK on ®bronectin. This upregulation could be
blocked with speci®c anti-avb6 or anti-av antibodies but not by
antibodies against avb5, a5b1, or b1. Several other studies have
shown integrin-dependent modulation of MMPs upon interaction
with ligands. For example, Huhtala et al (1995) reported that when
rabbit synovial ®broblasts bound to ®bronectin via a5b1 they
upregulated MMP-9, whereas adhesion via a4b1 decreased MMP-
9 expression. Melanoma cells modulate MMP-2 through avb3 and
bind the active form of the enzyme on the cell surface via this
integrin (Seftor et al, 1993; Brooks et al, 1996). Larjava et al (1993)
found that MMP-9 expression in keratinocytes could be stimulated
using antibodies against a3 and b1 subunits.
The role of integrins in cell migration is well documented.
Keratinocytes freshly isolated from skin are relatively immobile and
their ability to migrate develops with time in culture (Guo et al,
1990). avb5, avb6, a2b1, a3b1, and a5b1 have all been shown to
play a functional role in keratinocyte migration on their respective
Figure 5. Activation of MMP-9 increases NHK migration. Cell
migration assays were performed in the presence of speci®c integrin and
MMP-9 blocking antibodies, and speci®c MMP-9 and uPA chemical
inhibitors (in-1 and amiloride, respectively). Under serum-free conditions
NHK secrete pro-MMP-9 and so plasminogen was added to the assay
leading to activation of MMP-9. Error bars represent standard deviation.
(A) Zymogram demonstrating activation of MMP-9 by NHK on
addition of plasminogen to the migration assay. Control is supernatant
from a human OSCC line VB6, which produces large amounts of pro-
MMP-9. (B) Migration of NHK is inhibited by anti-avb6, av, and b1
antibodies. Maximum inhibition was produced by a combination of anti-
av and anti-b1. Anti-a5b1 produced an increase in cell migration.
MMP-9 and uPA inhibitors did not affect migration. Results are
expressed relative to an irrelevant control antibody (= 100). Error bars
represent standard deviation. (C) Addition of plasminogen increases
NHK migration. Results are expressed relative to the plasminogen-free
migration of cells treated with control antibody. Speci®c anti-MMP-9
antibody and an MMP-9 chemical inhibitor (in-1) abolished the increase
in migration. Furthermore, the uPA inhibitor amiloride (Amil) also
signi®cantly inhibited migration suggesting that MMP-9 is activated
through an enzymatic cascade involving the catalytic conversion of
plasminogen to plasmin.
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ligands, although many of these studies have been somewhat
contradictory (Toda et al, 1987; Adams and Watt, 1991; Kim et al,
1992a, b, 1994; Haapasalmi et al, 1996; Huang et al, 1998). We
demonstrate that, in NHK, avb6 functions in both adhesion to and
migration towards ®bronectin. Interestingly, inhibition of a5b1
reduced NHK adhesion to ®bronectin but produced an increase in
cell migration possibly suggesting that the function of this integrin
may be to anchor cells to ®bronectin. A reduction in migration was
observed using anti-b1 antibody, however, indicating that other
integrins of the b1 family may actively be involved in modulating
this cellular behavior.
The role of activated MMPs in cell migration where cells are
moving over a substrate (as opposed to cell invasion where cells
move through a substrate) is not clear, although several studies have
demonstrated a potential role for these enzymes in cell migration
(Pilcher et al, 1997; Giannelli et al, 1997). McCawley et al (1998)
found that EGF- and HGF-mediated keratinocyte migration was
coincident with induction of MMP-9. They further demonstrated
that inhibitors of MMP activity or addition of an MMP-9
neutralizing antibody prevented growth-factor-induced colony
dispersion, suggesting a functional role for MMP-9 induction
during this response (McCawley et al, 1998). Makela et al (1999)
recently demonstrated that MMP-2 is involved in random
keratinocyte migration on uncoated coverslips. Previous studies
have suggested that the role of MMP-2 in cell migration is not to
destroy matrix proteins but to modify them, exposing cryptic sites
that trigger cell migration (Giannelli et al, 1997). It is also possible
that adherent cells use activated enzyme to degrade the matrix
(endogenous or exogenous) to which they are attached, making
cells less adherent and allowing them to move more freely. Palecek
et al (1997) demonstrated the role of cell adhesion in migration and
showed that optimal migration was reached at a point between cells
being ``too adherent'' and ``not adherent enough''.
Activation of MMP-9 produced a signi®cant increase in NHK
migration towards ®bronectin. MMP-9 is produced in proenzyme
form by NHK and under serum-free conditions, as in migration
assays, is not activated. Previous studies have suggested that MMP-9
may be activated through an enzymatic cascade involving the
generation of plasmin by the uPa (Juarez et al, 1993; Ramos-
DeSimone et al, 1999). Con®rming these previous studies, addition
of plasminogen to the migration assays resulted in activated MMP-9
and produced a signi®cant increase in migration towards
®bronectin (Fig 5). The increased migration was inhibited by an
anti-MMP-9 antibody (which prevents activation of the enzyme), a
speci®c MMP-9 chemical inhibitor, and a uPA inhibitor,
amiloride, which suggests that activation of MMP-9 is catalyzed,
at least partially, through the conversion of plasminogen to plasmin.
These data suggest that, whereas migration of NHK is not MMP-9
dependent, activation of MMP-9 does increase migration. As
wounds contain signi®cant amounts of plasmin and plasminogen
(Lund et al, 1999), this could provide a mechanism to activate
MMP-9 in vivo. Furthermore, the subcellular localization of MMP-
9 to the terminal aspects of ®lopodia in monensin-treated cells
suggests a cellular mechanism for controlling the location of MMP-
9 activity, and that ®lopodia may play a role in keratinocyte
movement. Intriguingly, a recent study has demonstrated that
urokinase receptor (uPAR) may act as a ligand for several integrins
and modulates cell behavior accordingly. The similar subcellular
distribution of avb6 and MMP-9 raises the possibility of a similar
interaction (Tarui et al, 2001).
In summary, the upregulation of avb6 by wound keratinocytes
has been demonstrated by immunohistochemistry in several clinical
studies but there are few data to suggest a possible biologic role
(Breuss et al, 1995; Clark et al, 1996; Haapasalmi et al, 1996). For
the ®rst time, we provide experimental evidence that the increased
expression of avb6 by NHK results in coordinate changes, which
promote a more migratory phenotype. Thus we show that
increased expression of avb6 results in a ®bronectin-dependent
increase in pro-MMP-9, that MMP-9 activity increases avb6-
dependent migration, and that this may be further dependent on
plasmin activation. The results suggest a key role for avb6 in these
processes, and indicate a coordinated link between avb6 expression
and upregulation of MMP-9.
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